Woodline Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Buy |
815,485
+1,838
| +0.2% | +$25.7K | 0.06% | 399 |
|
|
2025
Q1 | $11M | Hold |
813,647
| – | – | 0.07% | 345 |
|
|
2024
Q4 | $15.6M | Sell |
813,647
-5,348
| -0.7% | -$103K | 0.11% | 255 |
|
|
2024
Q3 | $18.6M | Buy |
818,995
+418,080
| +104% | +$9.51M | 0.16% | 202 |
|
|
2024
Q2 | $5.22M | Sell |
400,915
-38,007
| -9% | -$494K | 0.05% | 331 |
|
|
2024
Q1 | $7.69M | Buy |
+438,922
| New | +$7.69M | 0.07% | 305 |
|
|
2023
Q3 | – | Sell |
-168,060
| Closed | -$4M | – | 752 |
|
|
2023
Q2 | $4M | Buy |
168,060
+48,611
| +41% | +$1.16M | 0.05% | 327 |
|
|
2023
Q1 | $3.04M | Sell |
119,449
-204,690
| -63% | -$5.21M | 0.04% | 368 |
|
|
2022
Q4 | $9.47M | Buy |
324,139
+28,265
| +10% | +$826K | 0.13% | 220 |
|
|
2022
Q3 | $6.07M | Sell |
295,874
-256,497
| -46% | -$5.26M | 0.08% | 264 |
|
|
2022
Q2 | $6.39M | Buy |
552,371
+331,114
| +150% | +$3.83M | 0.1% | 224 |
|
|
2022
Q1 | $4.09M | Sell |
221,257
-36,413
| -14% | -$673K | 0.07% | 262 |
|
|
2021
Q4 | $5.09M | Buy |
+257,670
| New | +$5.09M | 0.07% | 277 |
|